Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.718 USD | +0.98% | -1.05% | -19.33% |
Business Summary
Number of employees: 6
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephan Jackman
CEO | Chief Executive Officer | 48 | 20/18/20 |
David Katzoff
DFI | Director of Finance/CFO | 63 | 01/19/01 |
William Horne
CHM | Chairman | 55 | 01/16/01 |
Henry Nisser
BRD | Director/Board Member | 56 | 01/19/01 |
James Turner
LAW | General Counsel | 49 | 01/21/01 |
Kenneth Cragun
PRN | Corporate Officer/Principal | 63 | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Gustafson
BRD | Director/Board Member | 64 | 01/21/01 |
Todd Ault
FOU | Founder | 54 | 25/16/25 |
William Horne
CHM | Chairman | 55 | 01/16/01 |
Jeffrey Oram
BRD | Director/Board Member | 56 | 01/21/01 |
Henry Nisser
BRD | Director/Board Member | 56 | 01/19/01 |
Lynne McGrath
BRD | Director/Board Member | 69 | 01/21/01 |
Stephan Jackman
CEO | Chief Executive Officer | 48 | 20/18/20 |
Andrew Woo
BRD | Director/Board Member | 61 | 01/21/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,866,846 | 4,831,824 ( 70.36 %) | 0 | 70.36 % |
Company contact information
Alzamend Neuro, Inc.
3480 Peachtree Road NE Suite 103
30326, Atlanta
+844 722 6333
http://www.alzamend.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.33% | 4.88M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- ALZN Stock
- Company Alzamend Neuro, Inc.